NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%
NIFTY23,8981.14%
SENSEX76,6641.29%
BANKNIFTY56,0900.38%
NIFTY IT28,5315.29%
PHARMA22,5801.77%
AUTO25,6530.68%
FMCG50,7660.73%
METAL12,7470.31%
REALTY778.001.35%
ENERGY39,9040.23%

Procter & Gamble Surges 3% After Reporting Exceeding Third-Quarter Profits

Procter & Gamble (P&G) shares experienced a significant increase of more than 3% on Friday following the announcement of fiscal third-quarter profits that surpassed Wall Street projections. The American consumer products leader cautioned that the soaring oil costs will have an approximate $1 billion after-tax impact on its fiscal 2027 earnings.

This projected profit reduction ranks among the most significant outside the aviation industry, which heavily depends on petroleum. European competitor Nestle has also cautioned about rising expenses stemming from the Strait of Hormuz closure, while Nivea-manufacturer Beiersdorf is weighing price increases later this year should raw material costs persist in rising.

The earnings hit for P&G's fiscal period starting in July reflects the effect of oil prices surging from $60 per barrel prior to the hostilities to nearly $100 currently on plastic and paper packaging, plus shipping fees. P&G mentioned it was prepared to navigate these obstacles, including several force majeure notices from direct vendors who could no longer fulfill shipments.

Read also: Dollar Slips as DOJ Drops Probe of Fed Chair Powell, Clearing Path for Warsh Nomination

P&G's third quarter organic sales, which excludes factors like mergers and exchange rate shifts, grew 3% in the company's third fiscal quarter ending March 31, beating even the most bullish analyst forecasts. The manufacturer of Tide detergent and Herbal Essences shampoo also disclosed volume growth that exceeded projections during that timeframe.

Key Financial Performance Metrics

QuarterOrganic Sales GrowthVolume Growth
Q3 20263%Exceeded Projections
Q2 2026N/AN/A
Q1 2026N/AN/A

P&G has concentrated in recent months on creating upgraded versions and formulas of its lineup and promoting them as more efficient than rival offerings, a plan that seems to be succeeding. In a release, CEO Shailesh Jejurikar noted the firm achieved “wide-ranging growth across segments” and is boosting capital expenditure. P&G largely kept its guidance for the existing fiscal year ending in late June, yet now anticipates increased commodity expenses of roughly $150 million, after taxes.

Read also: Reliance Industries Nears Green Ammonia Supply Deals with International Partners

P&G, with a total cost of goods sold in 2025 reaching $40.85 billion, also noted a $150 million fourth-quarter impact due to commodity-related inflation, feedstock risks, and logistical hurdles from the Middle East crisis. The company anticipates fiscal 2026 earnings per share will land at the bottom of its 0% to 4% growth target.

"We're increasing investments to accelerate momentum with consumers despite the challenging geopolitical and economic environment," said Shailesh Jejurikar.

Investor Takeaway

Investors should be cautious of potential earnings reductions due to rising oil costs.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.